Arava:

Arava
Rheumatoid Arthritis
Arava Side Effects
Liver Damage
Other Illnesses
Resources
Back to Defective Drugs


Main Navigation:

Home
About Health Dangers
Contact Us

Subscribe to our Newsletter
for news and updates.


 

 

Arava and Liver Damage

There is growing concern over Arava's effects on the liver. High levels of liver enzymes occur in up to 5% of Arava patients. The American College of Rheumatology last summer warned doctors to take special care by repeatedly testing patients' livers for signs of harm and high levels of liver enzymes. But there is evidence that Arava cause serious liver problems.

European health officials reported that over 200 Arava patients have suffered liver problems after taking Arava. The European Agency for the Evaluation of Medicinal Products issued an urgent warning last year to patients and doctors about the drug's toxicity. In the U.S., the consumer group Public Citizen has petitioned the Food and Drug Administration (FDA) to remove Arava from the market.

Arava was first marketed in the United States in September 1998 to treat rheumatoid arthritis. Over the next three years, the FDA received reports of at least 130 cases of severe liver toxicity, including 56 hospitalizations and twelve deaths. Two of the people who died were in their twenties.

Arava and Methotrexate

Since Arava and methotrexate (an older drug also used to treat rheumatoid arthritis) work equally well, and methotrexate also bears a warning about possible liver damage, Public Citizen's Health Research Group compared the two. There were six times more cases of liver damage among Arava users than methotrexate users - even though there were 6.8 million (5.5 times) more prescriptions filled for methotrexate than Arava during that time.

Public Citizen's petition is supported by Dr. David E. Yocum, former chair of the FDA's Arthritis Drugs Advisory Committee. Yocum said he agrees that Arava should be withdrawn from the market. "I do not believe that the general rheumatologist understands or has any knowledge about these serious and potentially life-threatening complications," Yocum said in a letter to Public Citizen. "I also agree that providing a black box warning concerning these issues may not be effective since no one can predict who will suffer from these complications."


Arava and Liver Damage

Disclaimer